---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-026385"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:16:31.323958+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics shareholders approve reverse stock split up to 1-for-30

## Summary
- Special meeting on Dec 5, 2025 approved amendment for reverse stock split.
- Vote: 26,465,960 for, 4,213,378 against, 194,746 abstain – passed.
- Board authorized to set final ratio between 1-for-2 and 1-for-30 within 12 months.
- No other proposals were voted on at the special meeting.

## SEC filing metadata
- accession: 0001493152-25-026385
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/0001493152-25-026385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-026385
- JSON: https://secwatch.observer/filing/0001493152-25-026385.json
- Plain text: https://secwatch.observer/filing/0001493152-25-026385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.